Sizzling Stocks: Aemetis (NASDAQ:AMTX), United Continental Holdings (NYSE:UAL), Cheniere Energy Partners LP Holdings, LLC (NYSEMKT:CQH), Rosetta Genomics (NASDAQ:ROSG), Cepheid (NASDAQ:CPHD)


Aemetis, Inc. (NASDAQ:AMTX) announced that Eric McAfee, the Company’s Chairman and CEO, was named as one of the Top 125 People in the Advanced Bioeconomy by the international industry publication, Biofuels Digest. The list includes US Secretary of Agriculture Tom Vilsack, Poet CEO Jeff Lautt, Secretary of Energy Ernest Moniz, Advanced Biofuels Association President Michael McAdams and US Secretary of the Navy Ray Mabus. On Tuesday shares of Aemetis, Inc. (NASDAQ:AMTX) closed at $3.88. Company’s sales growth for last 5 years was 194.60%.

United Continental Holdings, Inc. (NYSE:UAL) said Jan 22, it earned $28 million in the fourth quarter, falling short of Wall Street estimates. United’s quarterly profit, equivalent to 7 cents per share,is down from $140 million in the same quarter of 2013. But without $433 million of special, one-time expenses for such items as severance and benefits costs, it would have earned$461 million in the quarter, an increase of 86 percent year-over-year, or $1.20 per share. That missed the average analyst estimate of $1.22 per share. United Continental Holdings, Inc. (NYSE:UAL) in last trading activity fell -2.03% to close at $67.97. Company weekly performance is -5.33% while its quarterly performance stands at 28.71%. United Continental Holdings, Inc. (NYSE:UAL) is -8.79% away from its 52 week high.

Morgan Stanley upgraded shares of Cheniere Energy Partners LP Holdings (NYSE:CQH) from an equal weight rating to an overweight rating in a report issued on Friday, TheFlyOnTheWall.com reports. On last trading day Cheniere Energy Partners LP Holdings, LLC (NYSEMKT:CQH) advanced 0.56% to close at $23.15. Its volatility for the week is 2.22% while volatility for the month is 3.28%. Cheniere Energy Partners LP Holdings, LLC (NYSEMKT:CQH) monthly performance is 0.43%.

On Jan 20, Rosetta Genomics, Ltd. (NASDAQ:ROSG), announces the publication of an article in the Journal of Kidney Cancer in support of the use of the Rosetta Kidney Cancer Test™. Rosetta Genomics, Ltd. (NASDAQ:ROSG) has institutional ownership stands at 4.20%. In last trading activity company’s stock closed at $2.94.

On Jan 29, Cepheid (NASDAQ:CPHD) reported after the close of the market on Thursday a 16 percent year-over-year increase in its fourth quarter revenues. The Sunnyvale, Calif.-based firm said that for the three months ended Dec. 31, 2014 it had revenues of $131.5 million, up from $113.3 million in Q4 2013. It beat the consensus Wall Street estimate of $125.3 million. On last trading day Cepheid (NASDAQ:CPHD) fell -0.89% to close at $56.58. Its volatility for the week is 4.25% while volatility for the month is 3.64%. CPHD’s sales growth for past 5 years was 22.50% and its EPS growth for past 5 years was -13.00%. Cepheid (NASDAQ:CPHD) monthly performance is 4.55%.


Leave a Reply

Your email address will not be published. Required fields are marked *